Skip to main content

Table 1 Regional estimates of VT- and BPND for test-, and retest scans

From: The pharmacokinetics of [18F]UCB-H revisited in the healthy non-human primate brain

Brain region

2TCM

2TCM-c

1TCM

Logan (t* = 60)

2TCM-c

VT [mL/cm3]

VT [mL/cm3]

VT [mL/cm3]

VT [mL/cm3]

k3/k4 (BPND)

Mean

 ± 

SEM

Mean

 ± 

SEM

Mean

 ± 

SEM

Mean

 ± 

SEM

Mean

 ± 

SEM

Striatum

Test

15.3

 ± 

2.25

15.0

 ± 

1.11

14.2

 ± 

1.29

15.8

 ± 

1.15

1.16

 ± 

0.36

Retest

14.1

 ± 

0.96

15.3

 ± 

0.93

14.8

 ± 

0.61

15.7

 ± 

1.04

1.12

 ± 

0.39

Thalamus

Test

15.6

 ± 

1.98

15.0

 ± 

1.38

13.3

 ± 

1.17

14.9

 ± 

0.99

1.03

 ± 

0.25

Retest

13.0

 ± 

1.08

14.2

 ± 

1.06

13.4

 ± 

0.60

14.3

 ± 

1.11

0.97

 ± 

0.36

Cerebellum

Test

10.6

 ± 

0.08

9.70

 ± 

NA

9.8

 ± 

0.78

11.2

 ± 

0.68

1.24

 ± 

NA

Retest

12.3

 ± 

NA

13.3

 ± 

2.97

10.4

 ± 

0.82

11.1

 ± 

0.75

1.22

 ± 

0.42

White matter

Test

14.0

 ± 

2.37

13.8

 ± 

1.69

12.3

 ± 

1.13

13.9

 ± 

1.00

1.25

 ± 

0.16

Retest

12.6

 ± 

1.08

13.7

 ± 

1.61

12.5

 ± 

0.68

13.6

 ± 

1.23

0.83

 ± 

0.47

Frontal cortex

Test

16.3

 ± 

3.68

14.8

 ± 

2.15

13.8

 ± 

1.64

15.0

 ± 

1.59

1.25

 ± 

0.32

Retest

13.1

 ± 

0.66

14.7

 ± 

1.37

13.8

 ± 

1.15

14.8

 ± 

1.87

1.32

 ± 

0.40

Temporal cortex

Test

13.9

 ± 

1.60

14.8

 ± 

1.30

12.9

 ± 

0.83

14.1

 ± 

0.77

1.00

 ± 

0.24

Retest

14.0

 ± 

0.01

13.1

 ± 

0.76

13.0

 ± 

0.52

13.9

 ± 

0.91

0.97

 ± 

0.54

Parietal cortex

Test

15.5

 ± 

3.24

15.4

 ± 

1.54

14.3

 ± 

1.41

15.4

 ± 

1.35

1.08

 ± 

0.26

Retest

13.6

 ± 

0.36

16.1

 ± 

1.40

14.8

 ± 

0.75

15.7

 ± 

1.43

1.17

 ± 

0.29

  1. VT was estimated using 2TCM, 2TCM-c, 1TCM and Logan. BPND was estimated by k3/k4 using a 2TCM-c. Only estimates at < 25%SE were included. NA = undetermined